clivarin 3436 i.e. anti-xa/0,6 ml raztopina za injiciranje
abbott laboratories d.o.o. - natrijev reviparinat - raztopina za injiciranje - natrijev reviparinat 3436 anti-xa i.e. / 0,6 ml - reviparin
eprex 20.000 i.e./0,5 ml raztopina za injiciranje v napolnjenih injekcijskih
raztopina za injiciranje - eritropoetin
gadovist 1,0 mmol/ml raztopina za injiciranje v napolnjeni injekcijski brizgi
bayer d.o.o. - gadobutrol - raztopina za injiciranje v napolnjeni injekcijski brizgi - gadobutrol 1 mmol / 1 ml - gadobutrol
gingium 80 mg filmsko obložene tablete
lek d.d. - suhi ekstrakt lista ginka, kvantificiran - filmsko obložena tableta - suhi ekstrakt lista ginka, kvantificiran 80 mg / 1 tableta - list ginka
gadovist 1,0 mmol/ml raztopina za injiciranje v napolnjeni injekcijski brizgi
bayer d.o.o. - gadobutrol - raztopina za injiciranje v napolnjeni injekcijski brizgi - gadobutrol 1 mmol / 1 ml - gadobutrol
klimadynon filmsko obložene tablete
bionorica se - suhi ekstrakt korenike grozdnate svetlike - filmsko obložena tableta - suhi ekstrakt korenike grozdnate svetlike 2,8 mg / 1 tableta - korenika grozdne svetilke (cimicifuge)
blincyto
amgen europe b.v. - blinatumomab - predkroglomerna limfoblastna levkemija limfoma - antineoplastična sredstva - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.
brinavess
correvio - vernakalant hidroklorid - atrijska fibrilacija - srčna terapija - hitro pretvorbo nedavni nastop atrijsko fibrilacijo, da sinus ritem pri odraslih:za ne-operaciji bolniki: atrijska fibrilacija .
briviact (in italy: nubriveo)
ucb pharma sa - brivaracetam - epilepsija - antiepileptics, - briviact je indiciran kot dodatna terapija pri zdravljenju napadov s parcialnim nastopom s sekundarno generalizacijo ali brez nje pri odraslih in mladostnikih, starih od 16 let, z epilepsijo.
evoltra
sanofi b.v. - klofarabin - predkroglomerna limfoblastna levkemija limfoma - antineoplastična sredstva - zdravljenje akutno limfoblastno levkemijo, (vse), pri pediatričnih bolnikih, ki so ponovila ali so ognjevarni po prejemu vsaj dve predhodni režimi in če ni druge možnosti zdravljenja, predvidene za posledico trajno odgovor. varnost in učinkovitost sta bili ocenjeni pri študijah pri bolnikih ≤ 21 let pri začetni diagnozi.